MINNEAPOLIS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of ...

Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 3.3% in the morning session after the stock extended its positive momentum as a recent announcement of a $200 million ...

Inspire Medical Systems, Inc. announced strong financial performance for the fourth quarter and full year of 2024, reporting a 25% increase in revenue for Q4, totaling $239.7 million, and a 28% ...

Inspire Medical Systems, Inc. (NYSE:INSP) Q2 2025 Earnings Call Transcript August 4, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is $0.45, expectations were $0.22.

MINNEAPOLIS, July 19, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, ...

I assign a HOLD rating to INSP due to execution risk from Inspire V rollout delays, IT integration, and reimbursement timing. Management's lowered guidance and a questionable share buyback program ...

Inspire is scheduled to present at 12:45 p.m. Eastern Time. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available for two weeks following ...

The necessary software updates for Medicare claims processing did not take effect until July 1, 2025, meaning implanting centers could not bill for procedures, stalling early adoption. Delayed Inspire ...